Cargando…

C1q–HA Matrix Regulates the Local Synthesis of Hyaluronan in Malignant Pleural Mesothelioma by Modulating HAS3 Expression

SIMPLE SUMMARY: Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor characterized by poor prognosis due to late diagnosis and the absence of efficient first-line treatments. Hyaluronic acid (HA) and the complement protein C1q represent two pivotal players in the MPM tumor microenviro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vidergar, Romana, Balduit, Andrea, Zacchi, Paola, Agostinis, Chiara, Mangogna, Alessandro, Belmonte, Beatrice, Grandolfo, Micaela, Salton, Francesco, Biolo, Marco, Zanconati, Fabrizio, Confalonieri, Marco, Bulla, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865933/ https://www.ncbi.nlm.nih.gov/pubmed/33499323 http://dx.doi.org/10.3390/cancers13030416

Ejemplares similares

Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
por: Balduit, Andrea, et al.
Publicado: (2023)

Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth
por: Agostinis, Chiara, et al.
Publicado: (2017)

Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics Analysis Involving Human Carcinomas
por: Mangogna, Alessandro, et al.
Publicado: (2019)

Prognostic Implications of the Complement Protein C1q in Gliomas
por: Mangogna, Alessandro, et al.
Publicado: (2019)

Zinc Oxide Exerts Anti-Inflammatory Properties on Human Placental Cells
por: Balduit, Andrea, et al.
Publicado: (2020)

COVID-19, Pre-Eclampsia, and Complement System
por: Agostinis, Chiara, et al.
Publicado: (2021)

Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target
por: Agostinis, Chiara, et al.
Publicado: (2021)

The last word on COVID-19 vaccines and breastfeeding?
por: Balduit, Andrea, et al.
Publicado: (2023)

The Extracellular Matrix Influences Ovarian Carcinoma Cells’ Sensitivity to Cisplatinum: A First Step towards Personalized Medicine
por: Balduit, Andrea, et al.
Publicado: (2020)

Pathological Significance and Prognostic Value of Surfactant Protein D in Cancer
por: Mangogna, Alessandro, et al.
Publicado: (2018)

A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients
por: Bulla, Roberta, et al.
Publicado: (2023)

Differential Capability of Clinically Employed Dermal Regeneration Scaffolds to Support Vascularization for Tissue Bioengineering
por: Agostinis, Chiara, et al.
Publicado: (2021)

SARS-CoV-2 modulates virus receptor expression in placenta and can induce trophoblast fusion, inflammation and endothelial permeability
por: Agostinis, Chiara, et al.
Publicado: (2022)

The Inflammatory Feed-Forward Loop Triggered by the Complement Component C3 as a Potential Target in Endometriosis
por: Agostinis, Chiara, et al.
Publicado: (2021)

CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives
por: Cortes-Dericks, Lourdes, et al.
Publicado: (2017)

Hyaluronan (HA)-inspired glycopolymers as molecular tools for studying HA functions
por: Collis, Dominic W. P., et al.
Publicado: (2021)

Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage?
por: Ruaro, Barbara, et al.
Publicado: (2021)

The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients
por: Ruaro, Barbara, et al.
Publicado: (2021)

Genetic bases of C7 deficiency: systematic review and report of a novel deletion determining functional hemizygosity
por: Balduit, Andrea, et al.
Publicado: (2023)

Pleural mesothelioma in a circus worker
por: Mensi, Carolina, et al.
Publicado: (2021)

Hyaluronan and N-ERC/Mesothelin as Key Biomarkers in a Specific Two-Step Model to Predict Pleural Malignant Mesothelioma
por: Mundt, Filip, et al.
Publicado: (2013)

A longitudinal study of C1q and anti-C1q autoantibodies in homologous and heterologous pregnancies for predicting pre-eclampsia
por: Agostinis, Chiara, et al.
Publicado: (2022)

Uterine Immunity and Microbiota: A Shifting Paradigm
por: Agostinis, Chiara, et al.
Publicado: (2019)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair
por: Ganzinelli, Monica, et al.
Publicado: (2023)

Anti-Spike Antibodies Present in the Milk of SARS-CoV-2 Vaccinated Mothers Are Complement-Activating
por: Agostinis, Chiara, et al.
Publicado: (2023)

Hyaluronan production increases the malignant properties of mesothelioma cells
por: Li, Y, et al.
Publicado: (2001)

Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma
por: Vita, Emanuele, et al.
Publicado: (2021)

Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
por: Ruaro, Barbara, et al.
Publicado: (2022)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients
por: Ruaro, Barbara, et al.
Publicado: (2022)

New Immunohistochemical Markers for Pleural Mesothelioma Subtyping
por: Di Stefano, Iosè, et al.
Publicado: (2023)

Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
por: Ricciardi, Sara, et al.
Publicado: (2021)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Pleural mesothelioma – case report
por: Klawiter, Anna, et al.
Publicado: (2010)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p9fl7m27odfi1ai9b9u031n3cn